S312: IS BREXUCABTAGENE AUTOLEUCEL A COST-EFFECTIVE TREATMENT FOR REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA? A PHARMACOECONOMIC ANALYSIS IN THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM.
oleh: Monia Marchetti
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.